Press and Media

December 10, 2019

Biovotec has been awarded a Fast Track to Innovation grant under the SME Instrument financing scheme of the Horizon 2020.

Fast Track to Innovation (FTI) is a fully bottom up innovation support program, promoting close-to-market innovation activities, open only to indust...

November 20, 2018

We would like to use this opportunity to inform you that we have now started the human clinical safety trial in UK and the first patients are now enrolled. Read more

June 11, 2018

We are very pleased to announce that we late yesterday received the permission from MHRA (UK health authorities) to start the CE mark human trial, read more

March 14, 2018

We are pleased to inform that we have now received another MNOK 10,0 (tranche 2 of 3 tranches) from the investor consortium that joined us last fall. Read the letter

December 20, 2017

Biovotec has successfully completed its preclinical safety studies and is now ready to apply for its clinical studies, see attached for more information. 

October 11, 2017

Biovotec announces today that it has raised MNOK 10,0 in a private placement and has secured further funding of an additional MNOK 20,0 conditioned on reaching predefined milestones….

Press realease

March 31, 2017

Following inspections at its facilities in Oslo and Dublin, Biovotec has been awarded certification to the international quality standard ISO13485: Medical devices – Quality management systems – Requirements for regulatory purposes.  With the certification to ISO13485,...

Please reload

Media Contact:     +47 95 94 99 78

Recent Posts
Please reload

Please reload

Engebrets vei 3, 0275 Oslo, Norway                                                   © Biovotec AS                                                                       info@biovotec